Carlyle Group Inc.Carlyle Group Inc.

Institutional investor · Portfolio as of Q1 2020

SEC EDGAR SourceSEC Filings

Top Holdings14 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
PPDPPDDelisted

PPD INC

66.5M$1.2B50.2%
1 qtr
New
100
ONEMONEMDelisted

1LIFE HEALTHCARE INC COM

28.2M$511.1M21.7%
1 qtr
New
100
EVAEVA
Unit

ENVIVA PARTNERS LP

12.8M$340.7M14.4%
6 qtrssince 2018-Q4
Increased
63
31M$158.2M6.7%
6 qtrssince 2018-Q4
Unchanged
0

LIBERTY ENERGY INC

34.1M$91.6M3.9%$11.90-78.91%
6 qtrssince 2018-Q4
Unchanged
0
172.9M$29.9M1.3%
5 qtrssince 2019-Q1
Decreased
0

TALOS ENERGY INC

5M$28.5M1.2%$5.700.00%
1 qtr
New
69

SEACOR MARINE HLDGS INC

1.1M$4.7M0.2%$12.00-68.25%
6 qtrssince 2018-Q4
Unchanged
0
CIHCIHDelisted
ADR

CHINA INDEX HLDGS LTD

2.5M$3.3M0.1%
4 qtrssince 2019-Q2
Unchanged
0
??FANG HLDGS LTDDelisted
ADR
2.5M$3.3M0.1%
Unchanged
0

RING ENERGY INC

2.6M$1.7M0.1%$1.66-59.64%
3 qtrssince 2019-Q3
Unchanged
0

Sweetgreen, Inc.

174,170$1.5M0.1%
6 qtrssince 2018-Q4
Unchanged
0
6.4M$1.3M0.1%
6 qtrssince 2018-Q4
Unchanged
0
1.2M$306,0000.0%
6 qtrssince 2018-Q4
Decreased
0
$2.4B
AUM
14
Positions
Q1 2020
Filing
Rating · 1.5
Quarterly Portfolio Change
Not enough history yet
Activity profile
$ moved · Q1'20
New77%Increased6%Decreased6%Exited11%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.2 quarters
<1Q21%1-4Q21%1-2Y57%2Y+0%

Carlyle Group Inc. manages $2.4B across 14 positions as of Q1 2020. Top holdings: PPD (50.2%), ONEM (21.7%), EVA (14.4%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 1.5/5.0.

Q1 2020 Summary

Added 3 new positions, exited 1, increased 1, trimmed 2. Top move: PPD (NEW, conviction 100). Portfolio: $2.4B across 14 positions.

Top holdings by portfolio weight

Total AUM$2B
PPD50.16%
ONEM21.66%
EVA14.44%
ONESMART INT6.70%
LBRT3.88%
CS11.27%
TALO1.21%
SMHI0.20%
CIH0.14%
FANG HLDGS L0.14%
Other0.07%

Portfolio allocation by GICS sector

Sectors4
Unknown94.17%
Energy5.55%
Industrials0.21%
Consumer Cyclical0.07%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Unknown
Compare DNA across all funds
7-dimension quality assessment
Below Average(1.5 / 5.0)
Track RecordNo data
Conviction38
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Top Losers

Checking access…

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used